+ Reply to Thread
Page 1 of 2 1 2 LastLast
Results 1 to 10 of 13

Thread: Blockbuster approval in 4Q11(Mcap 10 M) Cash 27 M =MONSTER PICK

  1. #1
    Senior Member BiotechMaster is a splendid one to behold BiotechMaster is a splendid one to behold BiotechMaster is a splendid one to behold BiotechMaster is a splendid one to behold BiotechMaster is a splendid one to behold BiotechMaster is a splendid one to behold
    Join Date
    Jan 2010
    Location
    Frankfurt
    Posts
    232
    Rep Power
    106

    Default Blockbuster approval in 4Q11(Mcap 10 M) Cash 27 M =MONSTER PICK

    THIS STOCK IS ON THE MOVE ....

    THIS IS THE NEXT BIG MONSTER STOCK ..READ WHY

    This is a real unknown gem ,once investors discover this stock it will explode like a nuclear bomb .LOAD UP THE TRUCK WHILE YOU STILL CAN BECAUSE ITS TRADING SIGNIFCANTLY BELOW CASH LEVEL !!

    NDA filing for Blockbuster Marqibo next quarter and it could be approved before the end of this Year .

    MARKET CAP OF 10 MILLION MAKES ME A BIG LAUGH // TLON WILL MOVE INTO DOUBLE DIGITS IN THE COMING MONTHS (As an example 10$ per share means 270 Mil Market Cap even at 10$ A BIG JOKE !!

    Talon Therapeutics (TLON.OB)

    Market Cap: $10,4 Mil
    Cash: 27,2 Mil
    Price : 0.48 $

    Shares Out: 21,2 Mil


    New Presentation // A MUST READ !!
    http://www.talontx.com/pdf/talontx_corp_pres.pdf

    Marqibo® is poised for accelerated approval in 4Q 2011
    NDA submission and request for priority revue expected in 2Q 2011
    Sought indica<on =Adult Ph(--)ALL in 2nd relapse or that has failed 2lines of Rx
    35% overall response rate as 3rd-*6th line treatment in RALLY study
    20% complete response rate with impressive median dura<on and survival

    .................

    http://biotuesdays.com/2011/02/01/ta...al-of-marqibo/

    Talon Therapeutics (OTCBB:TLON) plans to submit a new drug application with the FDA for priority review of its Marqibo oncology drug in the second quarter this year and is hoping for accelerated approval in the final quarter of the year.

    “We are seeking accelerated approval based on data from our Phase 2 RALLY study where we demonstrated a 35% overall response rate using single agent Marqibo as third, fourth, fifth or sixth line treatment,” CEO Dr. Steven Deitcher says in an exclusive interview with BioTuesdays.com. “This is the most heavily pretreated and advanced Acute Lymphoblastic Leukemia (ALL) population that has ever been described or studied in the literature.”

    If Marqibo is cleared by the FDA for use in additional, larger indications, Talon is looking at a multibillion-dollar potential


  2. #2
    Administrator FavStocks has disabled reputation FavStocks's Avatar
    Join Date
    Jul 2009
    Location
    California
    Posts
    216
    Rep Power
    100

    Default

    I jumped into this one. I see some great potential here. Thanks for sharing this diamond in the rough

  3. #3
    Junior Member cschroder67 is on a distinguished road
    Join Date
    Mar 2011
    Location
    okc
    Posts
    5
    Rep Power
    30

    Default nice

    i have gone back and researched all of your posts vs pps and i am totally impressed.

  4. #4
    Junior Member postcard is on a distinguished road
    Join Date
    Mar 2011
    Location
    OKC
    Posts
    2
    Rep Power
    0

    Default Great Information

    Will resarch

    Thanks

  5. #5
    Member ljdavis is a jewel in the rough ljdavis is a jewel in the rough
    Join Date
    Mar 2010
    Location
    Raleigh
    Posts
    57
    Rep Power
    69

    Default

    down to .58.. bounce

  6. #6
    Junior Member austinhitz is on a distinguished road
    Join Date
    Mar 2011
    Location
    Houston
    Posts
    5
    Rep Power
    30

    Default

    You can listen to the company's conference call from this morning and it's ROTH OC Growth Stock Conference Presentation from March 15 by clicking on the link below.

    http://ir.talontx.com/events.cfm

  7. #7
    Junior Member cschroder67 is on a distinguished road
    Join Date
    Mar 2011
    Location
    okc
    Posts
    5
    Rep Power
    30

    Default

    thanks i appreciate the link. check eltp out. interesting little stock

  8. #8
    Administrator FavStocks has disabled reputation FavStocks's Avatar
    Join Date
    Jul 2009
    Location
    California
    Posts
    216
    Rep Power
    100

    Default

    Closed at the high of the day @ .90! I see this thing moving into dollar territory. Looks like people just starting to wake up and see this stock is *still* trading below cash and with a new NDA comming up I am sure this stock will grab peoples attention.

  9. #9
    Junior Member jzhang2013 is a jewel in the rough jzhang2013 is a jewel in the rough
    Join Date
    Mar 2011
    Location
    Boston
    Posts
    25
    Rep Power
    39

    Default

    Financial results: Total current assets 22,894,900 at the end of 2010. Seems to be still trading under cash. One question: Does the total liability of 35 million affect TLON's attractiveness?

  10. #10
    Junior Member jzhang2013 is a jewel in the rough jzhang2013 is a jewel in the rough
    Join Date
    Mar 2011
    Location
    Boston
    Posts
    25
    Rep Power
    39

    Default

    15.7M market cap, still trading below cash, good opportunity

+ Reply to Thread
Page 1 of 2 1 2 LastLast

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts